John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$290M |
| 2 |
BID
Sotheby's
BID
|
+$141M |
| 3 |
AGN
Allergan plc
AGN
|
+$96.9M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$92M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$82.7M |
| 2 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$51.9M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$42.4M |
| 4 |
AABA
Altaba Inc
AABA
|
+$33.8M |
| 5 |
Fox Class B
FOX
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.93% |
| 2 | Communication Services | 14.92% |
| 3 | Materials | 9.86% |
| 4 | Energy | 6% |
| 5 | Technology | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SES
51
DELISTED
Synthesis Energy Systems Inc.
SES
| $388K | 0.01% |
156,250
| – | – |
|
52
CALL
Bristol-Myers Squibb
BMY
$137B
| – | – |
-950,000
| Closed | -$45.3M |
|
|
53
Centene
CNC
$32.1B
| – | – |
-1,558,060
| Closed | -$82.7M |
|
54
Walt Disney
DIS
$186B
| – | – |
-5,533
| Closed | -$614K |
|
|
55
Fox Class B
FOX
$25.6B
| – | – |
-688,526
| Closed | -$24.7M |
|
56
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.74B
| – | – |
-100,000
| Closed | -$10.8M |
|
57
Kamada
KMDA
$475M
| – | – |
-785,525
| Closed | -$4.5M |
|
58
NXP Semiconductors
NXPI
$56.9B
| – | – |
-20,000
| Closed | -$1.77M |
|
59
ON Semiconductor
ON
$28.9B
| – | – |
-75,000
| Closed | -$1.54M |
|
|
WBC
60
DELISTED
WABCO HOLDINGS INC.
WBC
| – | – |
-30,000
| Closed | -$3.96M |
|
|
TVPT
61
DELISTED
Travelport Worldwide Limited
TVPT
| – | – |
-3,300,000
| Closed | -$51.9M |
|
|
ULTI
62
DELISTED
Ultimate Software Group Inc
ULTI
| – | – |
-20,300
| Closed | -$6.7M |
|
|
CELG
63
PUT
DELISTED
Celgene Corp
CELG
| – | – |
-100,000
| Closed | -$9.43M |
|
|
ATTU
64
DELISTED
Attunity Ltd
ATTU
| – | – |
-105,000
| Closed | -$2.46M |
|
Similar funds
John Paulson's Q2 2019 Portfolio in Review
As of Q2 2019, John Paulson held 64 positions worth $5.88B, up 23% from $4.76B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
John Paulson deployed $891M of net new capital in Q2 2019, opening 10 new positions and adding to 8 existing holdings. Its largest new stake was Anadarko Petroleum: 4,320,000 shares worth $305M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 43% a quarter earlier, followed by Communication Services and Materials.
On the sell side, the largest reduction was Red Hat Inc, an estimated $42.4M trimmed.
- John Paulson's largest Q2 2019 buy was Anadarko Petroleum: 4,320,000 shares worth $305M.
- John Paulson added most to Allergan plc in Q2 2019, an estimated $96.9M increase.
- John Paulson's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $42.4M.
- John Paulson fully exited Centene in Q2 2019, selling an estimated $82.7M.
- John Paulson's ten largest holdings make up 56% of its $5.88B portfolio in Q2 2019.
- John Paulson opened 10 new positions and closed 13 in Q2 2019.
- John Paulson's portfolio value rose 23% quarter-over-quarter to $5.88B.
Based on Paulson & Co's 13F filing for Q2 2019, filed 14 Aug 2019.